EUCTR2004-000930-35-IT进行中（未招募）不适用
An open-label extension study to study 100185, to evaluate long-term safety, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
An open-label extension study to Study 100185 to evaluate long-term saftey, efficacy and optimal dosing frequency of 750mg intravenous mepolizumab in subjects with hypereosinophilic syndrome.Hypereosinophilic syndrome (HES)MedDRA version: 7.0Level: LLTClassification code 10048643EUCTR2004-000930-35-BESmithKline Beecham plc84
招募中
1 期
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without InhibitorsHaemophiliaMedDRA version: 20.0Level: LLTClassification code: 10018937Term: Haemophilia A Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10018938Term: Haemophilia A (Factor VIII) Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10018939Term: Haemophilia B (Factor IX) Class: 10010331CTIS2022-500470-33-00Pfizer Inc.145
进行中（未招募）
1 期
A long-duration study to assess the safety and effectiveness of NBI-827104 in children with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep.Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep (EECSWS)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-006788-11-DKeurocrine Biosciences, Inc.24
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-SEAbbvie Deutschland GmbH & Co. KG130
进行中（未招募）
1 期
Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-951 in subjects with Parkinson's disease.MedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersParkinson's DiseaseEUCTR2019-004235-23-DEAbbvie Deutschland GmbH & Co. KG130